Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

• Status: Withdrawn
• Trial end date: 2016-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators are attempting to determine a less invasive method of treatment for postdural puncture headaches that can occur after regional anesthesia. The investigators will be evaluating the relief of headache with those subjects receiving treatment with a sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with post study treatment versus placebo, and potential side effects of those patients receiving study therapy as well as epidural blood patch.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wake Forest University Health Sciences
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists assigned class I-III

• age >/= 18 years

• experiencing a postdural puncture headache within 7 days of neuraxial analgesia rated >3/10 pain score

Exclusion Criteria:

• allergy to study medications <18 years of age pain score on presentationheadache